Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
11.4M
-
Shares change
-
+220K
-
Total reported value, excl. options
-
$631M
-
Value change
-
+$15.8M
-
Number of buys
-
43
-
Number of sells
-
-36
-
Price
-
$55.38
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2019
95 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2019.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4M shares
of 29.1M outstanding shares and own 39.19% of the company stock.
Largest 10 shareholders include FMR LLC (1.15M shares), Redmile Group, LLC (1.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.05M shares), BAKER BROS. ADVISORS LP (1.03M shares), ORBIMED ADVISORS LLC (995K shares), FRAZIER MANAGEMENT LLC (895K shares), BlackRock Inc. (753K shares), VANGUARD GROUP INC (615K shares), CITADEL ADVISORS LLC (537K shares), and STATE STREET CORP (456K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.